VITAMIN A IS REQUIRED for growth, vision, reproduction, morphogenesis, hematopoiesis, immune function, and differentiation of normal and malignant tissues. 1 Although complete absence of vitamin A is lethal, deficiency during development leads to a spectrum of well-characterized defects collectively called the fetal vitamin A deficiency (VAD) syndrome. Depletion and repletion studies showed that all trans RA (atRA) can substitute for most vitamin A requirements leading to the hypothesis that atRA is the active principle of vitamin A. While atRA can frequently supplant vitamin A, vision requires retinaldehyde, immune function requires 14-hydroxy-retroretinol 2 and reproduction requires an, as yet, unidentified derivative. These findings, together with the discovery of novel, bioactive retinoids in the embryo (described below) suggest that vitamin A regulates a large number of important biological processes via metabolism into a variety of known and unknown derivatives. Of particular interest is the requirement for retinoids in specifying the vertebrate anteroposterior (A/P) axis, especially their potential role in patterning the central nervous system (CNS). Many excellent reviews are available which treat various aspects of axial patterning (especially in the mouse) and what role retinoids might have in this process. [3] [4] [5] [6] [7] [8] This review describes recent evidence from loss-of-function experiments in chicken and Xenopus that establishes an indispensable role for retinoid signaling in patterning the CNS and in promoting neuronal differentiation.
Retinoid signaling pathways
RA excess produces a spectrum of developmental defects affecting many of the same tissues as VAD, e.g. the heart, CNS, eyes, ears and reproductive tissues. Sensitivity of the same embryonic tissues to RA deficiency or excess suggested that endogenous RA levels required precise regulation for development to proceed correctly. A large body of evidence exists linking retinoids to the regulation of developmentally significant genes. Among these are genes involved in determining positional identity along the anteroposterior axis.
The biological effects of RA are thought to be modulated primarily by the action of two classes of ligand activated transcription factors which are members of the nuclear hormone receptor superfamily (reviewed in refs 9, 10). The first types to be discovered were the retinoic acid receptors (RARs) which bind to and are activated by all-trans retinoic acid (atRA) at nanomolar concentration. 11, 12 RARs comprise a family of three genes, the products of which are three receptor subtypes. Each subtype has two or more isoforms which are the products of differential promoter usage and alternative mRNA splicing. Subsequently, a second class of RA receptor, the retinoid 'X' receptors (RXRs) was identified. RXRs were shown to be activated by, but not to bind atRA. 13 Retinoid 'X' was subsequently identified as 9-cis RA (9cRA) 14, 15 and the RXR family was also shown to contain at least three genes. 16 Interestingly, while atRA is specific for RARs, 9cRA is a pan agonist which binds to and activates RARs and RXRs with high affinity. RAR requires heterodimerization with RXR in order to bind its specific DNA response elements called RAREs (retinoic acid response elements) (Figure 1A) . In contrast, RXRs bind to RXREs as homodimers ( Figure 1B ). Both types of receptors regulate the transcription of response element-containing genes and provide a direct mechanism to link retinoid concentration and gene expression.
All of the RAR and RXR genes have now been disrupted in transgenic mice (ref 17 , reviewed in ref 18) . The most dramatic phenotypes are seen in mice where multiple receptor subtypes have been eliminated (see Ward and Morriss-Kay, this issue). The phenotypes observed vary depending on the exact combination of receptors missing. The knockouts Figure 1 . Multiple retinoid mediated signaling pathways (A) RAR and RXR heerodimerize to bind direct repeats separated by two or five nucleotides. In these heterodimers, RXR may bind ligand, depending on whether RAR is occupied and on the particular DNA-response element to which it is bound. 23, 87 (B)RXR can homodimerize on direct repeats separated by one nucleotide. These homodimers are transcriptionally activated by binding 9cRA. (C) RXR is an obligate heterodimeric partner for many other ligand dependent receptors including PPAR, VDR, and TR. In addition, RXR partners with numerous orphan nuclear receptors (OR). In some permissive heterodimers (e.g. RXR:LXR) RXR is able to bind ligand and transduce 9cRA signals while in others (e.g. RXR:TR) it is transcriptionally inactive. Permissive heterodimers thus provide a third mechanism for retinoid signaling to occur. (D) RXR can also partner with the orphan nuclear NGFI-B, which ordinarily binds to an extended half site sequence. RXR:NGFI-B heterodimers typically bind to direct repeats separated by five nucleotides and are transcriptionally activated by 9cRA. recapitulate many aspects of fetal VAD but also introduce novel phenotypes such as homeotic vertebral transformations and atavistic skeletal structures. 18 There is an interesting general correlation between the posteriorizing effects of RA excess and anterior Hox gene overexpression and between the anteriorizing effects of RAR compound knockouts and Hox gene knockouts (reviewed in ref 5) . These have also pointed to an important role for the retinoid regulation of Hox gene expression in axial patterning.
In addition to the major retinoid response pathways it should be noted that RXR is a heterodimeric partner for a larger variety of known and orphan nuclear receptors (reviewed in ref 19) (Figure 1C ). This opens the possibility that additional retiniod effects could be mediated via activation of RXR in permissive heterodimeric complexes either alone, as exemplified by the activation of LXR:RXR heterodimers by 9cRA, 20 or in combination with the ligand of the partner, as with RAR:RXR heterodimers. 21 23 Synthetic compounds exist which selectively activate RXR in heterodimeric complexes 24, 25 hence it is possible that endogenous compounds with similar selectivity also exist. Lastly RXR can modulate the activity of at least two orphan nuclear receptors which ordinarily bind to DNA as monomers (NGFI-B, Nurr1) ( Figure 1D) . 26, 27 This multitude of retinoiddependent signaling pathways underlies the ability of retinoids to regulate diverse biological processes. In addition, all four types of pathways (Figure 1 ) function during embryogenesis which multiples the number of potential downstream genes under retinoid control. This makes it important to identify the endogenous retinoids functioning during development.
Endogenous bioactive retinoids
Endogenous bioactive retinoids have been described in the early embryos of typical vertebrate model systems. atRA has been reported in the early embryos of zebrafish, 28 chicken 29 and mouse, 30 although as described below, some of the methods employed may not be capable of discerning the identity of the active compound. Endogenous, bioactive retinoids have been reported from Xenopus embryos, however, there is some disagreement about which retinoids are present and at what amounts. To enable direct comparisons between differently reported results, I have used 1 µ1 and 1 mg as estimates of embryonic volume and mass and recalculated the reported concentrations. Durson and colleagues first reported the presence of ~150 nM atRA in the Xenopus neurula 31 and later reported 4-oxo-tRA at ~20 nM. 32 Chen et al 33 used a reporter cell assay to identify total embryonic retinoids and found ~110 nM of retinoic acid equivalent activity at the neurula stage. Since their assay measured the biological activity of whole embryo extracts, which contain numerous retiniods in addition to retinoic acids, their finding should be considered an upper limit for the total RA-equivalent concentration. Creech Kraft and colleagues reported atRA and 9cRA in the early neurula each at approximately 120 ng/g which translates to nearly 800 nM total retinoic acid. 34 We could not detect atRA or 9cRA in the embryo but did identify oxo-retinoids at quantities ranging from 0-13 nM (4-oxo-retinol), 50-144 nM (4-oxo-retinaldehyde), and 12-22 nM (4-oxo-RA) depending on the stage of development assayed. 35 The total concentration of these three RAR activators in the neurula is ~92 nM, hence they represent the bulk of the bioactive retinoids and the total amount is relatively close to that measured for whole embryo extracts. 33 The relatively large values obtained for retinoids which may not even be present in the embryo probably derives from the method of identification. Compounds may be unambiguously identified by employing multiple independent methods to characterize them. HPLC with single wavelength ultraviolet absorption detection was used in the two studies which gave high concentrations for atRA and 9cRA. 31, 34 While this method may be sufficiently accurate for resolving mixtures of standards or identifying metabolites of added labeled compounds, the complex biochemical environment of the early embryo can easily lead to misidentification of co-migrating compounds. In contrast, Pijnappel et al 32 used HPLC with photodiode array detection (which gives a complete UV absorbance profile rather than a single wavelength readout) and two column systems to identify 4-oxo-RA and obtained virtually identical results to Blumberg et al, who used HPLC, photodiode array detection, multiple column systems, mass spectroscopy and a sensitive bioassay to identify retinoids. 35 All three oxo-retinoids present in the Xenopus embryo are potent and selective activators for RARs. 35, 36 This led to the conclusion that 4-oxo derivatization, rather than representing a degradation pathway as had been previously assumed, results in the conversion of retinol and retinal to bioactive hormones. 35, 36 This suggests that the spectrum of bioactive retinoids is broader than previously suspected. The main conclusion from the study of Xenopus embryonic retinoids is that receptor agonists are present in the embryo at the time when patterning is underway and at concentrations which strongly activate the receptors. This is also the time of maximal embryonic sensitivity to exogenous RA. Taken together, these data support a potential role for retinoid signaling in early development.
Neural induction
The vertebrate nervous system is induced by signals emanating from the dorsal mesoderm, or organizer, that divert the ectoderm away from an epidermal and towards a neural fate. At the same time, signals from the organizer pattern the neural ectoderm along the A/P and D/V axis. The currently favored paradigm for neural induction is the 'activation-transformation' model ( Figure 2 ). 37, 38 In this two-step model, ectoderm is induced to form anterior neural tissue by vertical signals from the underlying mesoderm (activation). Later, this anterior neural tissue is transformed to produce the full spectrum of anteroposterior structures by both vertical signals from the mesoderm and planar signals traveling through the ectoderm (reviewed in refs 39, 40) . The activationtransformation model is supported by experiments which showed that A/P pattern was progressively specified after an initial induction to cement gland, which is considered the most anterior neural tissue in Xenopus. 41 Moreover, all direct neural inducers described to date, namely, noggin, chordin, follistatin, the dominant negative activin type II and BMP-4 type I receptors, induce neural tissue of anterior character. [42] [43] [44] [45] [46] These findings all support a model where the basal state of the neural ectoderm is anterior and that additional factors are required to generate the more posterior parts of the nervous system. This two-step process has been interpreted as a 'two signal' model of neural induction. 47 Much progress has been made in elucidating the identity and function of the 'activating' factor, however, the identity of the endogenous transforming factor(s) has remained elusive.
What are the expected properties of a neural transforming factor? In order to be considered an endogenous transforming factor, the candidate should possess several properties. 48 First, it should have the required activity, i.e. it should posteriorize. Second, it should be expressed when and where transformation occurs. Third, inhibition of its function should anteriorize the embryo. Fourth, it should be transmissible through tissue, both vertically and in the plane of the ectoderm. Lastly, the degree of transformation should ideally be concentrationdependent as has been suggested for the endogenous transforming signal. 40 RA was first proposed to be involved in neural development when it was demonstrated that exogenously applied RA produces a concentration-dependent truncation of anterior, and enhancement of posterior structures in Xenopus embryos 31, 41 through its influence on the embryonic mesoderm and ectoderm. 49, 50 At low concentrations, RA suppresses anterior and enhances posterior development within the hindbrain, without grossly affecting more anterior parts of the brain 51 while at high concentrations it causes anterior truncations 31, 51 reflected by suppression of anterior markers such as Otx2, 52, 53 Emxl,2 53 and Dlx1. 53 In addition, atRA leads to an anterior shift in the expression of many Hox genes (e.g. B1, B2, B3, B7). 5, [53] [54] [55] RA can also mimic the action of endogenous signals involved in inducing posterior gene expression in the Xenopus nervous system. The hypothesis that RA is the endogenous agent of posterior neural transformation 31, 56 was challenged by observations which demonstrated a lack of coordinate posterior transformations by exogenous RA, 51, 57 inhibition of tail structures by RA, 49 inconsistent response of posterior genes to exogenous RA application (e.g. no increase in the posterior marker Xhox3 by RA) 41, 49, 56, 58 and no obvious positional shifts resulting from localized application of RA. 59 The main problem in establishing what role retinoid signaling truly plays in development is that all of these experiments were based on gain-of-function by addition of exogenous RA. Hence while retinoids are clearly sufficient to produce effects similar to posteriorization, there were, until recently, no experiments which address the question of its necessity in the same processes.
Is retinoid signaling necessary and sufficient for neural posteriorization?
In order to fully understand the role of retinoid signaling in development it is necessary to perform loss-of-function experiments. Several different strategies for achieving loss-of-function are possible. The earliest and simplest test of retinoid function comes from depletion/repletion experiments. The embryo is rendered vitamin A-deficient by dietary or other means, and either studied for developmental effects or repleted with aRA at various times during development to assay the requirements for RA in particular processes. Despite the large body of literature concerning the fetal vitamin A deficiency (VAD) syndrome, there has been relatively little published concerning the effects of VAD on axial patterning. An exciting recent result was published by Maden and colleagues 60 who showed that quail deficient in vitamin A had considerable defects in axial patterning. They detected alterations in the expression patterns of Hox-A2, Hox-B1, Hox-B4, Krox-20 and FGF-3 which, taken together, led them to conclude that the posterior rhombomeres [4] [5] [6] [7] [8] had been lost. In contrast, they detected no alterations in the expression of dorsoventral markers, sonic hedgehog, islet-1 and Pax-3. This suggests that retinoid signaling is only required for A/P and not D/V patterning.
The other strategies to attain loss-of-function rely on modulating the activity of retinoid receptors. A current concept of how RARs function is illustrated in Figure 3A -C. 61 A central feature is that RARs heterodimerize with RXRs and bind DNA in the absence of ligand. In the unliganded state these heterodimers recruit co-repressor proteins and actively suppress transcription ( Figure 3A) . Upon the binding of an agonistic ligand, the receptor undergoes a conformational change which leads to co-repressor release and basal transcription levels ( Figure 3B ). The liganded receptor is now free to recruit co-activator proteins which, together with the transcriptional machinery, leads to activated transcription ( Figure 3C ). It is possible to interfere with these processes at various steps and it could be presumed that different modes of interference would result in qualitatively different results.
Retinoid antagonists interfere with the binding of RA or other agonistic ligands and are assumed to prevent the formation of the activated transcription complex ( Figure 3D ). In addition, one could speculate that compounds exist which stabilize the repressed complex rather than just preventing formation of the activated complex, virtually locking the system in the repressed state. This type of antagonist actually exists and is termed an 'inverse agonist' to distinguish it from the 'neural antagonists' which disrupt agonist binding but do not repress basal transcription. 62 Similarly, the ability of agonists to destabilize the repressed complex and stabilize the activated complex varies and corresponds, in part, to differences in potency of activation. The agonist/ antagonist approach is quite specific for the pathway under study, however, localized effects are difficult or impossible to achieve. RAR antagonists have been used to great advantage in resurrecting a role for RA in limb patterning 63 but have not yet been widely employed in A/P patterning studies. Carrasco and colleagues have tested the ability of an RAR antagonist to alter the expression of Hox genes in chicken and Xenopus (ref 55, A. Carrasco, personal communication). They showed that while RA treatment led to an anterior expansion of Hox-B7 and C6 expression in chicken and Xenopus (posteriorization), treatment with the antagonist reduced the levels and extent of Hox-B7 and C6 expression (anteriorization). 55 The expression of the hindbrain marker Krox-20 was shifted anteriorly by RA and posteriorly by the antagonist which is also consistent with RA functioning to posteriorize the axis (A. Carrasco, personal communication).
Because RARs require dimerization with RXR in order to function, it is possible to modulate their activity by interfering with dimerization as originally proposed by Herskowitz. 64 One way to create such a 'dominant negative' receptor is by overexpressing a truncated RAR or another receptor which can sequester RXR in complexes which are incapable of binding to RAREs ( Figure 3E ). Since the resulting dimer is merely nonfunctional, it should be possible to reconstitute normal activity by adding back an excess of functional partner or wild type receptor. A potential problem with this approach is that RXR is a required dimeric partner for numerous other receptors present during development and so one could have difficulty distinguishing between effects resulting Due to the similarity between the repression elicited by unliganded wild type receptors and the activation domain truncations, it is unlikely that this type of dominant negative can be rescued by wild type receptor (which also represses) or ligand (which is unable to dissociate corepressor). from inhibition of RAR and those which derive from inhibiting another RXR-dependent pathway.
Several studies employed this type of dominant negative approach. Overexpressed RARγ ligand binding domain was microinjected into embryos and shown to block, in part, the teratogenic effects of added RA. 65 Others used the thyroid hormone receptor or its mutant derivative v-erbA to sequester RXR and demonstrated reduced susceptibility to RA-teratogenesis and decreased induction of RA-response genes such as Xlim-1 and Hox-D1. [66] [67] [68] v-erbA injection was also able to reduce the expression of Hox-D1 in whole embryos. 68 Microinjection of another nuclear receptor, COUP-TFI, which likely functions similarly, was shown to impair the induction of RA-responsive genes and also reduced expression of the hindbrain marker Krox-20. 69 An alternative way to create dominant negative receptors relies on the interaction between the receptor and co-repressor protein(s) ( Figure 3F ). Several groups have shown that receptors lacking the carboxyl-terminal activation domain behave as dominant transcriptional repressors. Although these receptors are capable of binding ligand 70, 71 the lack of the activation domain prevents the conformational change which leads to co-repressor dissociation. 72 Thus this type of dominant negative receptor simultaneously sequesters RXR and ligand while constitutively interacting with co-repressor proteins to block transcription from RA target genes, even in the presence of RA or other receptor agonists. Since the wild type receptor also interacts with co-repressor proteins it would not be expected to rescue this type of dominant negative receptor.
We employed this type of dominant negative receptor, together with a constitutively active receptor created by fusing the wild type receptor with the strong transactivation domain from the herpes simplex virus protein VP-16 73 to evaluate the result of dominant gain or loss of retinoid signaling. 74 This is equivalent to a local increase or decrease in retinoid levels. These constructs were microinjected unilaterally into Xenopus embryos and the effects on A/P marker genes assayed. As would be predicted if retinoid signaling is required for posteriorization, the dominant negative receptor led to expansion of the forebrain and anterior midbrain as measured by posterior expansion of the forebrain marker Otx-2, and a posterior coordinate shift in the expression domains of en-2 and Krox-20 ( Figure 4 ). Also consistent with an endogenous posteriorizing role for retinoid signaling, the expression of posterior markers Xlim-1, N-tubulin and Hox-B9 was reduced or eliminated ( Figure 4) . Interestingly, while the rhombomere 3 band of Krox-20 was shifted toward the posterior, the more posterior rhombomere 5 band was eliminated (Figure 4) . Increased retinoid signaling, mediated by expression of the constitutively active receptor, led to the opposite effect. These posteriorized embryos were characterized by decreased forebrain size (and a reduced Otx-2 domain) and an anterior coordinate shift, and a decrease in the expression levels of en-2 and Krox-20 ( Figure 4) . Others used a different dominant negative RAR isoform and showed loss of the posterior marker Hox-D1, and compression of Krox-20 expression in the hindbrain although no changes in Otx or Hox-B9 were noted (H. Sive, personal communication). The Figure 4 . Anteroposterior positional shifts caused by localized perturbation of retinoid signaling. The leftmost set of bars depicts the normal expression domains of some useful A/P markers. Otx-2 marks the forebrain and anterior midbrain. En-2 marks the border between the midbrain and hindbrain. Krox-20 marks rhombomeres 3 and 5 of the hindbrain while Hox-B9 is a spinal cord marker. Injection of the constitutively active receptor (which locally increases retinoid signaling) leads to reduction or loss of Otx-2, rostral shifts and decreases in the expression domains of En-2 and Krox-20. In about 50% of the embryos, en and Krox-20 staining is lost altogether. There is no discernable effect on Hox-B9 expression. In contrast, injection of the dominant negative receptor (which locally decreases retinoid signaling) leads to caudal expansion of Otx-2 and caudal shifts in the expression of en-2 and the r3 band of Krox-20 expression. The r5 Krox-20 band is always lost and Hox-B9 expression is greatly reduced or eliminated.
conclusion from these results is that retinoid signaling through xRARs is essential to correctly restrict the expression of anterior genes and to enable the expression of posterior marker genes. Hence retinoids are excellent candidates to comprise one important part of the posteriorizing signal. The hindbrain appears to be extremely sensitive to the levels of retinoid signaling as was also shown by the vitamin A deficiency experiments.
Retinoid signaling and activation/transformation
What is the relationship between these new results and the status of the posteriorizing signal in the activation transformation model? It had been previously shown that basic fibroblast growth factor (bFGF) could posteriorize anterior neuroectoderm, in vitro and many inferred an endogenous role in neural induction and patterning (refs 75-77, reviewed in 47). Others showed that eFGF could posteriorize the axis via induction of downstream genes Xcad3 and Hox-A7 in vivo. 78 Because eFGF is appropriately expressed (notochord and posterior mesoderm) and inhibition of FGF signaling via overexpression of the dominant negative FGF receptor, XFD, reduced the expression of the posterior markers Hox-A7 and Xcad-3 but not the anterior markers Hox-B1 and Otx-2 it was suggested that eFGF is a good candidate for at least part of the posterior transforming signal. 78 In contrast to these results, others demonstrated that transgenic embryos expressing XFD (and non-mosaically deficient in FGF signaling) showed strong inhibition of posterior mesoderm but only limited effects on A/P patterning of the nervous system, suggesting that signaling through FGF receptors is not essential for neural posteriorization. 79 In support of this contention it was recently shown that RA could posteriorize anterior neuroectoderm injected with XFD while FGF could not. 80 Thus, both retinoid and FGF signaling can posteriorize anterior neural tissue in vitro.
As described above, we showed that blocking endogenous retinoid signaling alone is sufficient to ablate three posterior neural markers in vivo (although the embryos do have tails). 74 Maden et al showed that retinoid deficient quail embryos had severe patterning defects in the posterior hindbrain. 60 The simplest interpretation of these results is that neither retinoid signaling nor FGF signaling alone is sufficient to posteriorize both the embryonic mesoderm and neuroectoderm, in vivo. It could well be that FGF and retinoids act synergistically to promote posteriorization as was suggested previously based on transplantation experiments. 58 It is also not excluded that signaling through other RARs and RXRs or as yet unidentified FGF-like receptors could be involved in restricting anterior, and promoting posterior development. Additional factors such as members of the vertebrate hedgehog or Wnt gene families could also play a role in posteriorization. 81 More experiments will be required to determine the precise role of each component, however, it seems clears that retinoids comprise an indispensable part of the posteriorizing signal, in vivo.
Retinoid signaling and neuronal differentiation
Retinoids were hypothesized to play an important role in the development of the CNS primarily due to the ability of RA excess or retinoid deficiency to elicit serious patterning defects. Additional evidence comes from cell culture studies which showed that atRA treatment could alter neural differentiation of embryonal carcinoma cells (reviewed in ref 3). Treatment with atRA induces the differentiation of P19 teratocarcinoma cells to neurons and astroglia 82, 83 and causes cultured neuroblastoma cells to produce structures resembling dendrites whereas other differentiating treatments lead to the formation of structures resembling axons. 84 In addition, retinoid receptors, cellular binding proteins and bioactive retinoids are all found in the developing CNS. 3 Two lines of evidence support an endogenous role for RA in neuronal differentiation -depletion studies and dominant negative interference experiments. Maden et al showed that retinoid-deficient quail embryos are lacking in neural crest and fail to extend neurites into the periphery. 60 More specifically, it appears that neural crest cells are specified but fail to survive and migrate. In addition, those few neurons which did remain often followed chaotic migration paths, suggesting that positional identities were incorrect. More recent data from the same laboratory suggests that retinoids influence apoptosis of neuronal precursors in the chick. Vitamin A deficient quail embryos show a band of apoptosis first in the underlying mesoderm and later in the region fated to form rhombomeres 4-8 of the hindbrain (M. Maden, personal communication) . Thus it appears that incorrectly patterned cells fail to survive.
Two studies using dominant negative RARs showed that signaling through xRARα is required for neuronal differentiation. 74, 85 N-tubulin is a molecular marker for primary neurons, which normally differentiate in three stripes on either side of the dorsal midline at the neural plate stage and later give rise to sensory, motor and interneurons. 86 Microinjection of an xRARα1 dominant negative construct was able to prevent the expression of N-tubulin in the Xenopus neurula. It was concluded that retinoid signaling is required for differentiation of all three major classes of neurons since all three stripes of N-tubulin are affected by the dominant negative RAR. 74 Others used a different dominant negative receptor isoform, xRARα2·2, to show that the formation of sensory neurons is dependent on retinoid signaling as measured by expression of the neuronal markers XIF-3 and HNK-1. 85 Microinjection of the dominant negative receptor led to a dose-dependent decrease in the number of sensory neurons. Furthermore, microinjection of mRNA encoding the wild type xRARα2·2 together with xRXR led to the formation of ectopic neurons adjacent to the neural tube. 85 Additional experiments with inhibitors of cell proliferation excluded the possibility that the ectopic neurons formed as a result of increased proliferation of neuronal precursors, however, the mechanism by which they are formed remains unclear. Further experiments will be required to determine whether these ectopic neurons form beyond the boundaries of the neural plate or instead form within the neural plate but are not incorporated into the neural tube. The overall conclusion is that retinoid signaling plays a quantitative role in determining the number of primary neurons.
Future directions
As described above, the inescapable conclusion is that retinoid signaling is required for correct A/P neural specification and neuronal differentiation. Retinoids and their receptors are localized in the correct time and at the correct place to act as posteriorizing factors. Most importantly, inhibition of retinoid signaling interferes with patterning in a predictable way -posterior marker genes are lost and anterior genes extend more caudally than usual. Inhibition of retinoid signaling interferes with neuronal differentiation while excess signaling leads to the formation of ectopic neurons. The reciprocal nature of the phenotypes from increased or decreased signaling is completely consistent with a role for retinoids in the patterning process itself. However, many questions remain to be answered.
How exactly are retinoids and their receptors functioning to mediate patterning? What are the critical target genes? Is there, in fact, a gradient of bioactive retinoids from posterior to anterior and do retinoids act as gradient morphogens to specify position along the A/P axis? Do retinoids diffuse from a discrete source in the embryo or are there multiple sources at different times of development? How many factors are important for A/P patterning? Both FGF and retinoid signaling appear to have important roles in posteriorization of the axis ( Figure 5 ). FGF seems more important for mesodermal patterning whereas retinoids seem more important for neural patterning. It is possible, even likely, that these two pathways interact in the patterning process, hence one would like to know the mode and extent of such interactions. When do the retinoids act ( Figure 5 )? Both bioactive retinoids and functional receptors are present in the Xenopus egg hence there is no limit on how early the pathway could be activated.
Alterations in A/P neural patterning could result from changes in the underlying mesoderm, reflect a requirement for retinoid signaling in the ectoderm, or both. Results from gain-of-function studies suggest that both are important. Are retinoids acting on the inducing signals or the responding tissues? Localized receptor expression in defined regions of the embryo, combined with the types of embryological manipulations possible in Xenopus will go a long way toward clarifying these issues. Evaluating the responses of an extensive set of molecular markers in the manipulated Xenopus embryo and integrating this information with the available data from mouse and chicken embryos, should provide important insights into the processes underlying patterning. As Hox genes have already been shown to play important roles in A/P patterning, it will be critical to understand how they are regulated and which genes are downstream of retinoid receptors and upstream of Hox.
What is the role of retinoid signaling in neuronal differentiation? How does interfering with signaling lead to underproduction of neurons while excess signaling gives ectopic neurons? Added exogenous RA increases both the width of the neural plate and the number of primary neurons whereas inhibition of retinoid signaling drastically reduces the number of primary neurons but does not appear to alter neural plate boundaries much. It is likely that retinoids are modulating the activity of certain proneural genes which, in turn influence the number of primary neurons formed. The timing of neuronal differentiation is also linked to A/P patterning which may play a role in the ultimate number of neurons. 52 Understanding the role of retinoid signaling in the timing of A/P neural patterning and neuronal differentiation identifying possible connections between apoptosis and incorrect patterning will be of considerable interest.
Retinoids enjoyed a period of great prominence in embryological thinking during the 1980s only to become controversial, or even dismissed, as important patterning molecules in recent years. With the results of the past year or two it is now firmly established that retinoids are necessary for correct anterior neural patterning, necessary and sufficient for posterior neural patterning (especially in the hindbrain) and indispensable for neuronal differentiation in vivo. While many important questions remain, it seems clear that the search for answers will greatly illuminate our understanding of how the vertebrate body axis is formed. 
